Neurolens Strengthens Leadership for Accelerated Growth and Innovation
DALLAS, March 14, 2024 /PRNewswire/ -- Neurolens, on a mission to transform eye care, announces a strategic leadership restructure to fuel continued growth and innovation. This positions the company for even greater success in the evolving eyecare landscape.
Leveraging a strong foundation, the new structure combines seasoned leadership with strategic hires:
Davis Corley, visionary co-founder, returns as CEO to guide future growth.
Gregory Boisse leverages operational expertise to optimize efficiency as SVP of Operations.
Nathan Schomas applies customer focus to modern technology as SVP of Digital Innovation.
Bill Kastein strengthens customer relationships as VP of Strategic Partnerships & Business Development.
Kelly Vaupel expands brand awareness and market reach as VP of Marketing.
Eric Patnode empowers employees through leadership and development programs as VP of Leadership, Learning and Development.
Zach Dios drives product innovation as VP of Engineering.
Neurolens welcomes:
Katrina Forinash, Chief of Staff, bringing expertise in strategic execution and change management.
Chris Cahill, VP of Accounting & Finance, strengthening the team with his financial acumen.
Continuing leadership:
Danny Perales (CFO & COO)
Kaelin Currie (VP, Lab Operations)
Stéphane Arcand (VP, Canada)
Together, this talented and diverse leadership team will guide Neurolens in achieving its ambitious goals of revolutionizing eye care and establishing a leading position in the industry.
About Neurolens Neurolens commercializes breakthrough technology to improve vision care. With patented Contoured Prism technology, Neurolenses are the first and only prescription lenses that go beyond visual acuity to provide comfort for many adults who complain of headaches, neck/shoulder pain and eyestrain when using digital devices, reading, or doing detail work. The Neurolens Contoured Prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. Technology from Neurolens is only available to Independent Eye Care Providers.
Cardio Diagnostics Holdings, Inc. , a leader in the next generation of precision cardiovascular medicine technologies that combine proprietary AI algorithms with epigenetic and genetic biomarkers, today announced the publication of results from a...
Silence Therapeutics plc ("Silence" or the "Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision engineered medicines, today announced that Alistair Gray, who...
Altus Power, Inc. ("Altus Power" or the "Company") announced today that the Board of Directors has accepted the resignation of Lars Norell as a co-CEO and as a director of the Company, effective April 26, 2024, and has appointed Gregg Felton as sole...
CLEW, a clinical intelligence and predictive surveillance company, today announced the general availability of its FDA-cleared, AI-driven, intelligent clinical surveillance platform. Built upon proprietary, machine-learning derived prediction models...
CASE ("the Company"), a provider of high-end software development and cloud engineering services to the U.S. intelligence community and private industry, announced today that it has merged with CyberKinetics, a specialist provider of cloud-based...
OpenCV.ai, the team behind the widely used OpenCV library for computer vision, has announced the release of OpenCV 4.9.0 through collaboration with ARM Holdings. This new version brings important updates for Android developers, making using OpenCV in...